Excellent news and a good strong push forward to the main Goal of the company.
Credit given where credit is due, This is an Exceptional result. NMT now meets the the European battery Regulations for 2031, today. With improvements to product purity to come.
The Paragraph lifted from the announcement below actually gets me the most excited in the whole announcement. I don't recall previously any mention of China as a final destination of any of the product.
"Primobius has received strong interest in its LiF product from the lithium electrolyte supply chain and will be
providing samples under material testwork agreements with leading Chinese precursor and electrolyte
manufacturers. Further improvements to product purity are expected to be achieved over the coming
months."
Love them or loathe them China is the leader in all things EV at the moment and that is just a fact. If we can access that market without Losing the IP through Industrial espionage that would be HUGE news.
We might still be somewhat in the gutter share price wise but this has just strengthened my resolve..... the market is just yet to wake up and I believe we will not be worried about the price now, we will see it as a gift looking back. Not to say their won't be a cap raise in our future, the company itself has said it might happen, but would aim to make it only after materially good news has been announced which should rerate the price accordingly.
Good luck all, will be interesting to see if HNR get some love today with this news also.
- Forums
- ASX - By Stock
- NMT
- Ann: Primobius - Outstanding New Lithium Flowsheet Results
NMT
neometals ltd
Add to My Watchlist
1.37%
!
7.2¢

Ann: Primobius - Outstanding New Lithium Flowsheet Results, page-7
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
7.2¢ |
Change
-0.001(1.37%) |
Mkt cap ! $55.39M |
Open | High | Low | Value | Volume |
7.3¢ | 7.3¢ | 7.0¢ | $103.0K | 1.434M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 146786 | 7.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.2¢ | 3363 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 62112 | 0.071 |
4 | 224000 | 0.070 |
2 | 53650 | 0.069 |
2 | 154459 | 0.068 |
4 | 171400 | 0.067 |
Price($) | Vol. | No. |
---|---|---|
0.073 | 9087 | 1 |
0.078 | 96516 | 1 |
0.080 | 36036 | 3 |
0.083 | 17000 | 1 |
0.085 | 525 | 1 |
Last trade - 15.59pm 27/06/2025 (20 minute delay) ? |
Featured News
NMT (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online